Muscle stimulators are making their way into the mainstream day by day and playing a crucial role in improve health conditions.
Muscle stimulators are making their way into the mainstream day by day and playing a crucial role in improve health conditions. From elite athletes to patients suffering from unregulated blood supply in lower parts of legs, these stimulators can significantly improve the outcomes of muscles. Medical device manufacturers are developing devices by targeting various issues in a human body. From upgrading the current version to gaining approvals for new devices, manufacturers have been instrumental in attracting new customers and raising their stakes in the Market. The launch of innovative devices that would solve various issues in the human body will continue in the coming years.
According to the report published by Allied Market Research, the global muscle stimulator market is estimated to reach $183.88 million by 2030. Following are some of the activities taking place across the world.
To Download the Research Analysis https://www.alliedmarketresearch.com/request-sample/11557
The launch of new products is one of the major trends across the world as manufacturers aim to take muscle stimulator devices to the next level. Compex, one of the leading technologically advanced muscle stimulator device manufacturers, launched an upgraded device Wired 3.0. This device is aimed at improving muscle recovery, warm-up, strength, and pain management for athletes. There are three kits and each level caters to different needs. These levels include Edge, Performance, and Sport Elite. The Edge has an assortment of four programs, Performance has six, and Sports Elite has 10. Each program in these three kits different is targeted to improve capabilities of athletes in different areas of recovery, strength, and pain management. Such devices are expected to help athletes and raise the market share of the company.
As some of the devices have been launched, some gained approval from the regulatory bodies and will be launched soon. The U.K.-based Sky Medical gained an approval from the U.S. Food and Drug Administration (FDA) for its geko device. This device is a wearable muscle stimulator and assists in regulating the blood flow in lower parts of legs. It stimulated the central nerve at the top of the shin and regulates the blood flow through arteries and veins of lower limbs. The wearable device can be worn at the bottom of knees and the signals are transmitted to calves, ankles, and feet to improve the blood flow. The deeper veins can be stimulated without application of external force and a complete mobility can be achieved. This device is effective in lowering down fluid-based swelling and preventing blood clots. The approval for these devices would open up avenues for commercialization for market players.